Gerard J. Platenburg
Vermogen: 2 M $ op 31-08-2026
Vermogen: 2 M $ op 31-08-2026
Gerard J.
Platenburg was the founder of Prosensa Holding NV, serving as Chief Executive & Development Officer from 2002 to 2009.
Dr. Platenburg is the founder of ProQR Therapeutics NV, serving as Chief Scientific Officer & Executive Director since 2024.
Former job at ISA Pharmaceuticals BV as Chief Executive Officer from 2009 to 2014.
Former job at Pharming NV as Principal.
Education includes graduate and doctorate degrees from the University of Leiden, both conferred in 1987.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-03-2026 | 824.388 ( 0,6% ) | 2 M $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Oprichter | 21-02-2012 |
| Bedrijven | Functie | Einde |
|---|---|---|
ISA Pharmaceuticals BV
ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Develops novel therapeutic vaccines for cancer and infectious diseases | Algemeen Directeur | 01-01-2014 |
| PROSENSA HOLDING NV | Algemeen Directeur | 01-05-2009 |
Pharming NV
Pharming NV Miscellaneous Commercial ServicesCommercial Services Develops therapeutic products for the treatment of a range of medical indications | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Pharming NV
Pharming NV Miscellaneous Commercial ServicesCommercial Services Develops therapeutic products for the treatment of a range of medical indications | Commercial Services |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prosensa Holding NV
Prosensa Holding NV BiotechnologyHealth Technology Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders | Health Technology |
ISA Pharmaceuticals BV
ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Develops novel therapeutic vaccines for cancer and infectious diseases | Health Technology |
ProQR Therapeutics NV
ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau